If we want to avoid another Martin Shkreli or an EpiPen pricing fiasco, this is how we need to deal with … – The Independent


The Independent
If we want to avoid another Martin Shkreli or an EpiPen pricing fiasco, this is how we need to deal with
The Independent
Who is to blame when pharmaceutical firms price gouge? The answer might seem obvious. Many will say that responsibility lies with the greedy bosses of these companies. Since an outfit called Mylan acquired the “EpiPen” in 2007 the price of the

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd